Se connecter

Bibliographies thématiques / Ferric pyrophosphate / Articles de revues

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Ferric pyrophosphate.

Articles de revues sur le sujet « Ferric pyrophosphate »

Auteur : Grafiati

Publié le 7 juin 2025

Mis à jour le 2 août 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Ferric pyrophosphate ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Mallaci Bocchio, R., M. Lo Monaco, G. Natoli, S. Scibetta, and S. Corrao. "A Randomized Controlled Pilot Study to Compare the Efficacy of Different Iron Formulations: Sucrosomal Ferric Pyrophosphate, Micronized Microencapsulated Ferric Pyrophosphate, and Intravenous Ferric Gluconate." Current Topics in Nutraceutical Research 20, no. 4 (2022): 685–90. http://dx.doi.org/10.37290/ctnr2641-452x.20:685-690.

Texte intégral

Résumé :

Despite their gastrointestinal side effects, oral iron supplements are the first-line therapy in iron deficiency anemia. This study aims to compare different iron formulations in anemic outpatients. One-hundred and six outpatients with sideropenic microcytic hypochromic anemia (Hb < 12 g/dL for women, Hb < 13 g/dL for men) were enrolled and divided into two groups (Hb > 10 g/dL and Hb < 10 g/dL). One group was randomized (1:1) to receive sucrosomal ferric pyrophosphate or micronized microencapsulated ferric pyrophosphate, while the other group was randomized (1:1:1) to receive sucr

Styles APA, Harvard, Vancouver, ISO, etc.

2

Fidler, Meredith C., Thomas Walczyk, Lena Davidsson, et al. "A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man." British Journal of Nutrition 91, no. 1 (2004): 107–12. http://dx.doi.org/10.1079/bjn20041018.

Texte intégral

Résumé :

Ferric pyrophosphate is a water-insoluble Fe compound used to fortify infant cereals and chocolate-drink powders as it causes no organoleptic changes to the food vehicle. However, it is only of low absorption in man. Recently, an innovative ferric pyrophosphate has been developed (Sunactive Fe™) based on small-particle-size ferric pyrophosphate (average size 0·3 μm) mixed with emulsifiers, so that it remains in suspension in liquid products. The aim of the present studies was to compare Fe absorption of micronised, dispersible ferric pyrophosphate (Sunactive Fe™) with that of ferrous sulfate i

Styles APA, Harvard, Vancouver, ISO, etc.

3

Fidler, Davidsson, Zeder, Walczyk, Marti, and Hurrell. "Effect of Ascorbic Acid and Particle Size on Iron Absorption from Ferric Pyrophosphate in Adult Women." International Journal for Vitamin and Nutrition Research 74, no. 4 (2004): 294–300. http://dx.doi.org/10.1024/0300-9831.74.4.294.

Texte intégral

Résumé :

The effects of added ascorbic acid and particle size on iron absorption from ferric pyrophosphate were evaluated in adult women (9–10 women/study) based on erythrocyte incorporation of iron stable isotopes (57Fe or 58Fe) 14 days after administration. Three separate studies were made with test meals of iron-fortified infant cereal (5 mg iron/meal) and the results are presented as geometric means and relative bioavailability values (RBV, FeSO4 = 100%). The results of study 1 showed that iron absorption was significantly lower from ferric pyrophosphate (mean particle size 8.5 mum) than from FeSO4

Styles APA, Harvard, Vancouver, ISO, etc.

4

Tarczykowska, Agata, Niklas Engström, Darja Dobermann, Jonathan Powell, and Nathalie Scheers. "Differential Effects of Iron Chelates vs. Iron Salts on Induction of Pro-Oncogenic Amphiregulin and Pro-Inflammatory COX-2 in Human Intestinal Adenocarcinoma Cell Lines." International Journal of Molecular Sciences 24, no. 6 (2023): 5507. http://dx.doi.org/10.3390/ijms24065507.

Texte intégral

Résumé :

We previously showed that two iron compounds that are orally ingested by humans, namely ferric EDTA and ferric citrate, can induce an oncogenic growth factor (amphiregulin) in human intestinal epithelial adenocarcinoma cell lines. Here, we further screened these iron compounds, plus four other iron chelates and six iron salts (i.e., 12 oral iron compounds in total), for their effects on biomarkers of cancer and inflammation. Ferric pyrophosphate and ferric EDTA were the main inducers of amphiregulin and its receptor monomer, IGFr1. Moreover, at the maximum iron concentrations investigated (500

Styles APA, Harvard, Vancouver, ISO, etc.

5

Sakaguchi, Rao, Nakata, Nanbu, and Juneja. "Iron Absorption and Bioavailability in Rats of Micronized Dispersible Ferric Pyrophosphate." International Journal for Vitamin and Nutrition Research 74, no. 1 (2004): 3–9. http://dx.doi.org/10.1024/0300-9831.74.1.3.

Texte intégral

Résumé :

Unlike commercial ferric pyrophosphate, micronized dispersible ferric pyrophosphate (MDFP: SunActive FeTM) does not precipitate and is completely dispersible in liquid form. MDFP shows a sharp particle size distribution at a nanometer level, which is several times smaller than that of commercial ferric pyrophosphate. The bioavailability of MDFP was compared to ferric pyrophosphate, sodium ferrous citrate, and ferrous sulfate by three bioavailability tests in rats; namely the serum iron concentration curve, the hemoglobin regeneration efficiency, and Association of Official Analytical Chemists'

Styles APA, Harvard, Vancouver, ISO, etc.

6

Divya, Sri Keerthika B. Priyanka B. P. Harith Mahesh Gomasa Dr. Swathi Boddupally*. "Study On Efficacy and Compliance of Oral Supplements with Ferric Pyrophosphate and Ferrous Ascorbate in Iron Deficiency Anaemia During Pregnancy." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 1080–86. https://doi.org/10.5281/zenodo.15354355.

Texte intégral

Résumé :

Background: Iron deficiency anaemia in pregnancy is a nutritional disorder characterized by insufficient iron levels, leading to reduced haemoglobin production. This condition poses significant risks to both maternal and fatal health including increased chances of preterm birth, low birth, weight and maternal morbidity. It often results from inadequate dietary intake, poor iron absorption, or increased iron requirements during pregnancy. Early diagnosis and appropriate management through iron supplementation and dietary adjustments are crucial to mitigate adverse outcomes and promote healthy p

Styles APA, Harvard, Vancouver, ISO, etc.

7

Tsuchita, Hiroshi, Atsuko Kobayashi, Tadashi Kojima, et al. "Bioavailability of iron from ferric pyrophosphate." Journal of Agricultural and Food Chemistry 39, no. 2 (1991): 316–21. http://dx.doi.org/10.1021/jf00002a020.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Pratt, Raymond, Garry J. Handelman, Thomas E. Edwards, and Ajay Gupta. "Ferric pyrophosphate citrate: interactions with transferrin." BioMetals 31, no. 6 (2018): 1081–89. http://dx.doi.org/10.1007/s10534-018-0142-2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Gupta, Ajay, Raymond Pratt, and Bhoopesh Mishra. "Physicochemical characterization of ferric pyrophosphate citrate." BioMetals 31, no. 6 (2018): 1091–99. http://dx.doi.org/10.1007/s10534-018-0151-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Cercamondi, Colin I., Guus S. M. J. E. Duchateau, Rajwinder K. Harika, et al. "Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate." British Journal of Nutrition 116, no. 3 (2016): 496–503. http://dx.doi.org/10.1017/s0007114516002191.

Texte intégral

Résumé :

AbstractFe fortification of centrally manufactured and frequently consumed condiments such as bouillon cubes could help prevent Fe deficiency in developing countries. However, Fe compounds that do not cause sensory changes in the fortified product, such as ferric pyrophosphate (FePP), exhibit low absorption in humans. Tetra sodium pyrophosphate (NaPP) can form soluble complexes with Fe, which could increase Fe bioavailability. Therefore, the aim of this study was to investigate Fe bioavailability from bouillon cubes fortified with either FePP only, FePP+NaPP, ferrous sulphate (FeSO4) only, or

Styles APA, Harvard, Vancouver, ISO, etc.

11

He, Qiang, and Robert A. Sanford. "Characterization of Fe(III) Reduction by Chlororespiring Anaeromxyobacter dehalogenans." Applied and Environmental Microbiology 69, no. 5 (2003): 2712–18. http://dx.doi.org/10.1128/aem.69.5.2712-2718.2003.

Texte intégral

Résumé :

ABSTRACT Anaeromyxobacter dehalogenans strain 2CP-C has been shown to grow by coupling the oxidation of acetate to the reduction of ortho-substituted halophenols, oxygen, nitrate, nitrite, or fumarate. In this study, strain 2CP-C was also found to grow by coupling Fe(III) reduction to the oxidation of acetate, making it one of the few isolates capable of growth by both metal reduction and chlororespiration. Doubling times for growth of 9.2 and 10.2 h were determined for Fe(III) and 2-chlorophenol reduction, respectively. These were determined by using the rate of [14C]acetate uptake into bioma

Styles APA, Harvard, Vancouver, ISO, etc.

12

Fell, Lisa H., Danilo Fliser, and Gunnar H. Heine. "Ferric pyrophosphate: good things come to those who wait?" Nephrology Dialysis Transplantation 30, no. 12 (2015): 1942–44. http://dx.doi.org/10.1093/ndt/gfv287.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

Briguglio, Matteo, Silvana Hrelia, Marco Malaguti, et al. "Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial." Nutrients 12, no. 2 (2020): 386. http://dx.doi.org/10.3390/nu12020386.

Texte intégral

Résumé :

Altered martial indices before orthopedic surgery are associated with higher rates of complications and greatly affect the patient’s functional ability. Oral supplements can optimize the preoperative martial status, with clinical efficacy and the patient’s tolerability being highly dependent on the pharmaceutical formula. Patients undergoing elective hip/knee arthroplasty were randomized to be supplemented with a 30-day oral therapy of sucrosomial ferric pyrophosphate plus L-ascorbic acid. The tolerability was 2.7% among treated patients. Adjustments for confounding factors, such as iron absor

Styles APA, Harvard, Vancouver, ISO, etc.

14

Hurrell, Richard F., Manju B. Reddy, Sandra A. Dassenko, James D. Cook, and David Shepherd. "Ferrous fumarate fortification of a chocolate drink powder." British Journal of Nutrition 65, no. 2 (1991): 271–83. http://dx.doi.org/10.1079/bjn19910086.

Texte intégral

Résumé :

An evaluation was made into the usefulness of ferrous fumarate as an iron fortificant for an experimental chocolate drink powder targetted to children and adolescents. Organoleptically ferrous fumarate was acceptable when the chocolate drink powder was reconstituted in milk or water that was heated to < 80°. Unacceptable colour changes occurred, however, when boiling milk or water were used. In human Fe absorption studies when the Fe compounds were added to the chocolate drink immediately before consumption, ferrous fumarate was 3.31 % absorbed compared with 2.82% for ferrous sulphate and 2

Styles APA, Harvard, Vancouver, ISO, etc.

15

Micheletto, Marta, Elisa Gaio, Erik Tedesco, et al. "Intestinal Absorption Study of a Granular Form of Ferric Pyrophosphate." Metabolites 12, no. 5 (2022): 463. http://dx.doi.org/10.3390/metabo12050463.

Texte intégral

Résumé :

Iron deficiency is one of the most prevalent nutritional disorders worldwide. The standard treatment involves iron supplementation, but this task is challenging because of poor solubility and organoleptic issues. Moreover, the need to increase iron bioavailability represents a challenge for treating iron-related disorders. In this study, gastroresistance and iron intestinal absorption of an innovative granular formulation composed of ferric pyrophosphate, modified starch and phospholipids branded as Ferro Fosfosoma® was investigated. Gastroresistant properties were studied using standard proto

Styles APA, Harvard, Vancouver, ISO, etc.

16

Tian, Tian, Elena Blanco, Stoyan K. Smoukov, Orlin D. Velev, and Krassimir P. Velikov. "Dissolution behaviour of ferric pyrophosphate and its mixtures with soluble pyrophosphates: Potential strategy for increasing iron bioavailability." Food Chemistry 208 (October 2016): 97–102. http://dx.doi.org/10.1016/j.foodchem.2016.03.078.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

17

MB, Reddy. "Rapid and Reliable Method for Qualitative and Quantitative Assessment of Iron Fortificants Used for Flour Fortification." Food Science & Nutrition Technology 5, no. 6 (2020): 1–9. http://dx.doi.org/10.23880/fsnt-16000235.

Texte intégral

Résumé :

Food fortification with iron has potential to reduce anemia if the manufacturers comply with fortification standards using highly bioavailable and required quantities of iron. Our objective was to develop a quick and simple method to identify and quantify iron compounds commonly used for flour fortification to help agencies monitor fortification programs. Wheat and corn flours were fortified with 40-60 mg Fe/kg using ferric pyrophosphate, ferrous sulfate, ferrous citrate, ferrous fumarate, sodium ferric EDTA, and electrolytic iron. Using potassium thiocyanate with hydrochloric acid and hydroge

Styles APA, Harvard, Vancouver, ISO, etc.

18

Albright, Tyler, Akram Al-Makki, Rabih Kalakeche, and Brian Shepler. "A Review of Ferric Pyrophosphate Citrate (Triferic) Use in Hemodialysis Patients." Clinical Therapeutics 38, no. 10 (2016): 2318–23. http://dx.doi.org/10.1016/j.clinthera.2016.08.012.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

19

Nie, Shibin, Lei Song, Chenlu Bao, et al. "Synergistic effects of ferric pyrophosphate (FePP) in intumescent flame-retardant polypropylene." Polymers for Advanced Technologies 22, no. 6 (2009): 870–76. http://dx.doi.org/10.1002/pat.1590.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Hackl, Laura, Colin I. Cercamondi, Christophe Zeder, et al. "Cofortification of ferric pyrophosphate and citric acid/trisodium citrate into extruded rice grains doubles iron bioavailability through in situ generation of soluble ferric pyrophosphate citrate complexes." American Journal of Clinical Nutrition 103, no. 5 (2016): 1252–59. http://dx.doi.org/10.3945/ajcn.115.128173.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Navas-Carretero, S., A. M. Pérez-Granados, B. Sarriá, S. Schoppen, and M. P. Vaquero. "Iron Bioavailability from Pate Enriched with Encapsulated Ferric Pyrophosphate or Ferrous Gluconate in Rats." Food Science and Technology International 13, no. 2 (2007): 159–63. http://dx.doi.org/10.1177/1082013207077931.

Texte intégral

Résumé :

Fortifying food with iron has been widely studied as a strategy to prevent iron deficiency anaemia. This work comparatively assessed the bioavailability of two forms of iron, ferrous gluconate or ferric pyrophosphate encapsulated in liposomes (lipofer®), when used as fortificants in meat pate. Three groups of growing rats consumed during 28 days either a control diet (AIN-93G), or two diets prepared with enriched pate as the unique source of iron and fat. Body weight and diet intake were measured weekly, and during the last week faeces were collected. On day 28 animals were sacrificed, livers

Styles APA, Harvard, Vancouver, ISO, etc.

22

Shetty, A., J. V. Hawkins, and A. Gupta. "Peritoneal Dialysis Using Soluble Ferric Pyrophosphate as an Iron Supplement in Rabbits." Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 37, no. 1 (2017): 121–22. http://dx.doi.org/10.3747/pdi.2016.00045.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

Dellafera, Louis, Shan Wang, Lameesa Dhanani, Paula Dutka, Brian Malone, and Naveed Masani. "1100: Institutional Usage of Ferric Pyrophosphate Citrate in Reducing Erythropoiesis-Stimulating Agents." Critical Care Medicine 49, no. 1 (2020): 551. http://dx.doi.org/10.1097/01.ccm.0000730288.91343.6b.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

Shah, Hitesh H., Azzour D. Hazzan, and Steven Fishbane. "Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis." Seminars in Nephrology 36, no. 2 (2016): 124–29. http://dx.doi.org/10.1016/j.semnephrol.2016.02.007.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

Fishbane, Steven, and Hitesh H. Shah. "Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysis." Hemodialysis International 21 (April 2017): S104—S109. http://dx.doi.org/10.1111/hdi.12554.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Shen, Bolei, Maowen Xu, Yubin Niu, et al. "Sodium-Rich Ferric Pyrophosphate Cathode for Stationary Room-Temperature Sodium-Ion Batteries." ACS Applied Materials & Interfaces 10, no. 1 (2017): 502–8. http://dx.doi.org/10.1021/acsami.7b13516.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

27

Marbury, Thomas, Fred Heuveln, Eric Horst, and Raymond D. Pratt. "Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate." Journal of Clinical Pharmacology 62, no. 5 (2022): 681–88. http://dx.doi.org/10.1002/jcph.1997.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Gupta, Ajay, Neeta B. Amin, Anatole Besarab, et al. "Dialysate iron therapy: Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis." Kidney International 55, no. 5 (1999): 1891–98. http://dx.doi.org/10.1046/j.1523-1755.1999.00436.x.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

29

Zhu, Le, Dennis Miller, Deanna Nelson, and Raymond Glahn. "Soluble ferric pyrophosphate: A novel iron source for individuals with high iron needs." FASEB Journal 22, S2 (2008): 678. http://dx.doi.org/10.1096/fasebj.22.2_supplement.678.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

30

Navas-Carretero, Santiago, Ana M. Pérez-Granados, Beatriz Sarriá, and M. Pilar Vaquero. "Iron absorption from meat pate fortified with ferric pyrophosphate in iron-deficient women." Nutrition 25, no. 1 (2009): 20–24. http://dx.doi.org/10.1016/j.nut.2008.07.002.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

31

Li, Wentao, Ji Zhi Zhou, Jia Zhang, Jun Zhao, Yunfeng Xu, and Guangren Qian. "pH-Dependent improvement of pyrophosphate removal on amorphous ferric hydroxide by incorporating Ca2+." Chemical Engineering Journal 225 (June 2013): 372–77. http://dx.doi.org/10.1016/j.cej.2013.04.043.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

32

Wegmüller, Rita, Michael B. Zimmermann, Diego Moretti, Myrtha Arnold, Wolfgang Langhans, and Richard F. Hurrell. "Particle Size Reduction and Encapsulation Affect the Bioavailability of Ferric Pyrophosphate in Rats." Journal of Nutrition 134, no. 12 (2004): 3301–4. http://dx.doi.org/10.1093/jn/134.12.3301.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

33

Roe, Mark A., Rachel Collings, Jurian Hoogewerff, and Susan J. Fairweather-Tait. "Relative bioavailability of micronized, dispersible ferric pyrophosphate added to an apple juice drink." European Journal of Nutrition 48, no. 2 (2009): 115–19. http://dx.doi.org/10.1007/s00394-008-0770-3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

34

Hu, Shuang, Yuan Hu, Lei Song, and Hongdian Lu. "The potential of ferric pyrophosphate for influencing the thermal degradation of cotton fabrics." Journal of Thermal Analysis and Calorimetry 109, no. 1 (2011): 27–32. http://dx.doi.org/10.1007/s10973-011-1732-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

35

Lee, Kuo-Hua, Yang Ho, and Der-Cherng Tarng. "Iron Therapy in Chronic Kidney Disease: Days of Future Past." International Journal of Molecular Sciences 22, no. 3 (2021): 1008. http://dx.doi.org/10.3390/ijms22031008.

Texte intégral

Résumé :

Anemia affects millions of patients with chronic kidney disease (CKD) and prompt iron supplementation can lead to reductions in the required dose of erythropoiesis-stimulating agents, thereby reducing medical costs. Oral and intravenous (IV) traditional iron preparations are considered far from ideal, primarily due to gastrointestinal intolerability and the potential risk of infusion reactions, respectively. Fortunately, the emergence of novel iron replacement therapies has engendered a paradigm shift in the treatment of iron deficiency anemia in patients with CKD. For example, oral ferric cit

Styles APA, Harvard, Vancouver, ISO, etc.

36

Hurrell, Richard F., Manju B. Reddy, Joseph Burri, and James D. Cook. "An evaluation of EDTA compounds for iron fortification of cereal-based foods." British Journal of Nutrition 84, no. 6 (2000): 903–10. http://dx.doi.org/10.1017/s0007114500002531.

Texte intégral

Résumé :

Fe absorption was measured in adult human subjects consuming different cereal foods fortified with radiolabelled FeSO4, ferrous fumarate or NaFeEDTA, or with radiolabelled FeSO4or ferric pyrophosphate in combination with different concentrations of Na2EDTA. Mean Fe absorption from wheat, wheat–soyabean and quinoa (Chenopodium quinoa) infant cereals fortified with FeSO4or ferrous fumarate ranged from 0·6 to 2·2 %. For each infant cereal, mean Fe absorption from ferrous fumarate was similar to that from FeSO4(absorption ratio 0·91–1·28). Mean Fe absorption from FeSO4-fortified bread rolls was 1·

Styles APA, Harvard, Vancouver, ISO, etc.

37

Pratt, Raymond D., Dorine W. Swinkels, T. Alp Ikizler, and Ajay Gupta. "Pharmacokinetics of Ferric Pyrophosphate Citrate, a Novel Iron Salt, Administered Intravenously to Healthy Volunteers." Journal of Clinical Pharmacology 57, no. 3 (2016): 312–20. http://dx.doi.org/10.1002/jcph.819.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

38

Pratt, Raymond D. "Ferric Pyrophosphate Citrate Injection: No Clinical Drug Interaction with Unfractionated Heparin in Hemodialysis Patients." Journal of the American Society of Nephrology 31, no. 10S (2020): B6—B7. http://dx.doi.org/10.1681/asn.20203110s1b6b.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

39

Pyo, Euisun, Becky L. Tsang, and Megan E. Parker. "Rice as a vehicle for micronutrient fortification: a systematic review of micronutrient retention, organoleptic properties, and consumer acceptability." Nutrition Reviews 80, no. 5 (2022): 1062–85. http://dx.doi.org/10.1093/nutrit/nuab107.

Texte intégral

Résumé :

Abstract Context Previous reviews have focused on evaluating the efficacy and effectiveness of rice fortification, despite the need to also understand the outcomes of micronutrient retention, organoleptic properties, and acceptability to inform nutrition programs. Objective This systematic review aims to consolidate existing evidence on micronutrient retention, organoleptic properties, and acceptability of fortified rice. Data Sources Eligible articles were identified from 22 electronic databases and personal referrals and reviews. Study Selection Studies on rice fortified via extrusion or coa

Styles APA, Harvard, Vancouver, ISO, etc.

40

Davidsson, Lena, Peter Kastenmayer, Hanna Szajewska, Richard F. Hurrell, and Denis Barclay. "Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate." American Journal of Clinical Nutrition 71, no. 6 (2000): 1597–602. http://dx.doi.org/10.1093/ajcn/71.6.1597.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

Moretti, Diego, Michael B. Zimmermann, Rita Wegmüller, Thomas Walczyk, Christophe Zeder, and Richard F. Hurrell. "Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans." American Journal of Clinical Nutrition 83, no. 3 (2006): 632–38. http://dx.doi.org/10.1093/ajcn.83.3.632.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

42

Xu, Yunfeng, Hui Hong, Fei Yang, et al. "Removal behaviors and mechanisms of orthophosphate and pyrophosphate by calcined dolomite with ferric chloride assistance." Chemosphere 235 (November 2019): 1015–21. http://dx.doi.org/10.1016/j.chemosphere.2019.07.018.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

43

Lobo, Alexandre Rodrigues, Maria Lucia Cocato, Primavera Borelli, et al. "Iron bioavailability from ferric pyrophosphate in rats fed with fructan-containing yacon (Smallanthus sonchifolius) flour." Food Chemistry 126, no. 3 (2011): 885–91. http://dx.doi.org/10.1016/j.foodchem.2010.11.067.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Wang, Jiaqi, Cheng Song, Lixin Huo, Xingzu Wang, Hong Liu, and Xiaomei Zhang. "Nitrogen removal performance and thermodynamic mechanisms of Feammox mediated by ferric pyrophosphate at various pHs." Journal of Water Process Engineering 58 (February 2024): 104864. http://dx.doi.org/10.1016/j.jwpe.2024.104864.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

45

DOBBIN, Paul S., Julea N. BUTT, Anne K. POWELL, Graeme A. REID, and David J. RICHARDSON. "Characterization of a flavocytochrome that is induced during the anaerobic respiration of Fe3+ by Shewanella frigidimarina NCIMB400." Biochemical Journal 342, no. 2 (1999): 439–48. http://dx.doi.org/10.1042/bj3420439.

Texte intégral

Résumé :

A 63.9 kDa periplasmic tetrahaem flavocytochrome c3, designated Ifc3, was found to be expressed in Shewanellafrigidimarina NCIMB400 grown anaerobically with ferric citrate or ferric pyrophosphate as the sole terminal electron acceptor, but not in anaerobic cultures of the bacterium with other respiratory substrates. Ifc3 was purified to homogeneity and revealed by biochemical, spectroscopic and primary structure analyses to contain four low-spin bis-His-ligated c3-haems, with midpoint reduction potentials of -73, -141, -174 and -259 mV. A low-potential flavin was present in the form of non-cov

Styles APA, Harvard, Vancouver, ISO, etc.

46

Macdougall, Iain C. "Iron Supplementation: What's New?" Blood 130, Suppl_1 (2017): SCI—43—SCI—43. http://dx.doi.org/10.1182/blood.v130.suppl_1.sci-43.sci-43.

Texte intégral

Résumé :

Abstract Supplemental orally-administered iron has been available for centuries, but parenteral administration of iron as a therapeutic agent dates from the 1930s. The original agents were iron salts, and their administration to man was associated with severe and unacceptable side-effects even with doses of 4-8 mg. The modern-day practice of IV iron supplementation was transformed in the 1940s with the introduction of iron incorporated into a carbohydrate shell, to allow slow release in the circulation and rapid binding to plasma transferrin. The older iron-carbohydrate complexes included iron

Styles APA, Harvard, Vancouver, ISO, etc.

47

EVANS, L. J., and W. G. WILSON. "EXTRACTABLE Fe, Al, Si AND C IN B HORIZONS OF PODZOLIC AND BRUNISOLIC SOILS FROM ONTARIO." Canadian Journal of Soil Science 65, no. 3 (1985): 489–96. http://dx.doi.org/10.4141/cjss85-052.

Texte intégral

Résumé :

To investigate the content of amorphous forms of Fe, Al and Si in podzolic soils, the B horizons from 54 Humo-Ferric Podzols and 24 Eluviated Dystric Brunisols were sampled in northern Ontario. Dithionite-citrate-bicarbonate (DCB) Fed and Ald, acid NH4-oxalate Feo, Alo and Sio, Na-pyrophosphate Fep, Alp and Cp and NaOH-tetraborate Fet and Alt were determined on all samples. Feo/Fed ratios averaged 0.87 and suggested that most of the extractable Fe was amorphous. Inorganically bound Fe and Al in pyrophosphate extracts were estimated by addition of NH4OH to the extracts. The amount of inorganica

Styles APA, Harvard, Vancouver, ISO, etc.

48

Pratt, Raymond D., Sarah Grimberg, Joshua J. Zaritsky, and Bradley A. Warady. "Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis." Pediatric Nephrology 33, no. 11 (2018): 2151–59. http://dx.doi.org/10.1007/s00467-018-4014-3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

49

Zimmermann, Michael B., Rita Wegmueller, Christophe Zeder, et al. "Dual fortification of salt with iodine and micronized ferric pyrophosphate: a randomized, double-blind, controlled trial." American Journal of Clinical Nutrition 80, no. 4 (2004): 952–59. http://dx.doi.org/10.1093/ajcn/80.4.952.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

50

Eilander, Ans, Olumakaiye M. Funke, Diego Moretti, et al. "High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women." Journal of Nutrition 149, no. 5 (2019): 723–29. http://dx.doi.org/10.1093/jn/nxz003.

Texte intégral

Résumé :

ABSTRACT Background It is challenging to find an iron compound that combines good bioavailability with minimal sensory changes when added to seasonings or condiments. Ferric pyrophosphate (FePP) is currently used to fortify bouillon cubes, but its bioavailability is generally low. Previously, the addition of a stabilizer, sodium pyrophosphate (NaPP), improved iron bioavailability from a bouillon drink. Objective We assessed whether there is a dose-response effect of added NaPP on iron bioavailability from local meals prepared with intrinsically labeled FePP-fortified bouillon cubes in young Ni

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!